Dopaminergic Neuronal Loss and Dopamine-Dependent Locomotor Defects in Fbxo7-Deficient Zebrafish

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhao, Tianna ^a   Zondervan van der Linde, Herma ^a   Severijnen, Lies Anne ^a   Oostra, Ben A ^a   Willemsen, Rob ^a   Bonifati, Vincenzo ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE TRANSPORTER; F BOX ONLY PROTEIN 7; F BOX PROTEIN; MESSENGER RNA; PROTEIN P53; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIENCEPHALON; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO DEVELOPMENT; F BOX ONLY PROTEIN 7 GENE; GENE; GENE SILENCING; IN SITU HYBRIDIZATION; LOCOMOTION; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA SPLICING; VENTRAL TEGMENTUM; ZEBRA FISH;

ANIMALS; APOMORPHINE; BODY PATTERNING; BRAIN; DISEASE MODELS, ANIMAL; DOMPERIDONE; DOPAMINE; DOPAMINE ANTAGONISTS; EXONS; EXPRESSED SEQUENCE TAGS; F-BOX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRONS; LOCOMOTION; NEURONS; PARKINSONIAN DISORDERS; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; ZEBRAFISH;

ANIMALIA; DANIO RERIO; VERTEBRATA;

EID: 84868331106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048911     Document Type: Article

References (36)

1. Tolosa E, Wenning G, Poewe W, (2006) The diagnosis of Parkinson's disease. Lancet Neurol 5: 75-86.
2. Cookson MR, Bandmann O, (2010) Parkinson's disease: insights from pathways. Hum Mol Genet 19: R21-27.
3. Corti O, Lesage S, Brice A, (2011) What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 91: 1161-1218.
4. Bonifati V, (2012) Autosomal recessive parkinsonism. Parkinsonism Relat Disord 18 (Suppl 1): S4-6.
5. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, et al. (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41: 308-315.
6. Usenovic M, Knight AL, Ray A, Wong V, Brown KR, et al. (2012) Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity. Hum Mol Genet 21: 3785-3794.
7. Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, et al. (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72: 240-245.
8. Paisan-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, et al. (2010) Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25: 1791-1800.
9. Ho MS, Ou C, Chan YR, Chien CT, Pi H, (2008) The utility F-box for protein destruction. Cell Mol Life Sci 65: 1977-2000.
10. Zhao T, De Graaff E, Breedveld GJ, Loda A, Severijnen LA, et al. (2011) Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). PLoS One 6: e16983.
11. Bandmann O, Burton EA, (2010) Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 40: 58-65.
12. Kabashi E, Brustein E, Champagne N, Drapeau P, (2011) Zebrafish models for the functional genomics of neurogenetic disorders. Biochim Biophys Acta 1812: 335-345.
13. Ibanez CF, (2008) Catecholaminergic neuron survival: getting hooked on GDNF. Nat Neurosci 11: 735-736.
14. Holzschuh J, Ryu S, Aberger F, Driever W, (2001) Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 101: 237-243.
15. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI, (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388: 211-227.
16. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, et al. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15: 1714-1723.
17. Rink E, Wullimann MF, (2001) The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 889: 316-330.
18. Rink E, Wullimann MF, (2002) Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Brain Res Dev Brain Res 137: 89-100.
19. Flinn L, Mortiboys H, Volkmann K, Koster RW, Ingham PW, et al. (2009) Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 132: 1613-1623.
20. Fett ME, Pilsl A, Paquet D, van Bebber F, Haass C, et al. (2010) Parkin is protective against proteotoxic stress in a transgenic zebrafish model. PLoS One 5: e11783.
21. Anichtchik O, Diekmann H, Fleming A, Roach A, Goldsmith P, et al. (2008) Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 28: 8199-8207.
22. Sallinen V, Kolehmainen J, Priyadarshini M, Toleikyte G, Chen YC, et al. (2010) Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 40: 93-101.
23. Xi Y, Ryan J, Noble S, Yu M, Yilbas AE, et al. (2010) Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function. Eur J Neurosci 31: 623-633.
24. Bretaud S, Allen C, Ingham PW, Bandmann O, (2007) p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 100: 1626-1635.
25. Baulac S, Lu H, Strahle J, Yang T, Goldberg MS, et al. (2009) Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol Neurodegener 4: 12.
26. Sheng D, Qu D, Kwok KH, Ng SS, Lim AY, et al. (2010) Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet 6: e1000914.
27. Ren G, Xin S, Li S, Zhong H, Lin S, (2011) Disruption of LRRK2 does not cause specific loss of dopaminergic neurons in zebrafish. PLoS One 6: e20630.
28. Milanese C, Sager JJ, Bai Q, Farrell TC, Cannon JR, et al. (2012) Hypokinesia and reduced dopamine levels in zebrafish lacking beta- and gamma1-synucleins. J Biol Chem 287: 2971-2983.
29. Matsui H, Taniguchi Y, Inoue H, Kobayashi Y, Sakaki Y, et al. (2010) Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement. Neurosci Res 66: 151-161.
30. Adams JR, van Netten H, Schulzer M, Mak E, McKenzie J, et al. (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 128: 2777-2785.
31. Eisen JS, Smith JC, (2008) Controlling morpholino experiments: don't stop making antisense. Development 135: 1735-1743.
32. Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, et al. (2007) p53 activation by knockdown technologies. PLoS Genet 3: e78.
33. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF, (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
34. Turner DL, Weintraub H, (1994) Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev 8: 1434-1447.
35. Bai Q, Burton EA, (2009) Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site. Neuroscience 164: 1138-1151.
36. Thisse C, Thisse B, (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69.